Watermark
  Back to Search Results

BGB-A317-Sitravatinib-203

Terminated

Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-Sitravatinib-203

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05461794

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20222088

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan